UroMetrics logo
ProductsPress RoomAbout UsContact UsHome
Female Sexual DysfunctionErectile DysfunctionSite Map
Español EROS-CTD
Eros therapy
About
FAQ
Instructions
Distribution
For Health Care Professionals
Reimbursement
More Resources

UroMetrics, Inc.
CareLine: 877-774-1442
Phone: 763-398-0108
Fax: 763-398-0109

Or e-mail us at customercare@urometrics.com

UroMetrics Privacy Policy

For Physicians and Healthcare Providers

This page contains information specifically for physicians and other healthcare providers who diagnose and treat women with female sexual dysfunction. Female Sexual Dysfunction continues to gain recognition and awareness among physicians and women as a true medical condition.

Scientific Meetings & Conferences

Learn more about treating female sexual dysfunction by visiting UroMetrics at the following scientific meetings and conferences.

American College of Obstetricians and Gynecologists (ACOG)
Annual Clinical Meeting
New Orleans April 25-30, 2003

Eros Therapy™ — Prescription Information

Eros Therapy™ Clinical Studies

  • A Non-Pharmacological Method to Increase Vaginal Blood Flow in Patients with Sexual Arousal Disorder.
    Rachel N. Pauls, MD; Laura Berman, PhD; Jennifer Berman, MD; Los Angeles, CA
     
    The goal of this pilot study was to determine effects of the Eros Therapy on vaginal blood flow. Click for study results.
     
  • A Prospective Duplex Doppler Ultrasonographic Study in Women with Sexual Arousal Disorder to Objectively Assess Genital Engorgement Following Therapeutic Use with the Eros Therapy.
    Ricardo Munarriz, Lily Talakoub, Irwin Goldstein; Boston University, Boston, MA
     
    The aim of this prospective, IRB-approved study was to obtain objective information regarding the effectiveness of the Eros Therapy to increase genital blood flow to the clitoris following therapeutic use in women with sexual arousal disorder. Click for study results.
     
  • Initial Clinical Study
    Kevin Billups, M.D., Billups Institute for Sexual Health & Medicine, St. Paul, MN
    Irwin Goldstein, M.D., Boston University, Boston, MA
     
    The objective of this 32-subject study was to determine whether use of the Eros Therapy improved sexual arousal. Click for Study Results.
      
  • Follow-Up Study
    Steve Wilson, M.D. and Barbara Wilson, Wilson Urology, Van Buren, AR
     
    Nineteen subjects were enrolled in this study, 10 with symptoms of female sexual dysfunction and 9 without female sexual dysfunction. Click for Study Results.
Principal Investigators Location Objective
     
Kevin Billups, M.D.
Irwin Goldstein, M.D.
St. Paul
Boston
Evaluate the effectiveness of the Eros Therapy in improving symptoms of FSD in diabetic women.
     
A.J. Mundt, M.D.
Maryann Schroder, Ph.D.
Chicago Evaluate the effectiveness of the Eros Therapy in treating women who have undergone surgical procedures and radiation therapy to treat cervical cancer.
     
Eric Bieber, M.D.
Maryann Schroder, Ph.D.
Chicago Evaluate the effectiveness of the Eros Therapy in treating post-menopausal women with symptoms of female sexual dysfunction.
     

 

  • On-Going Clinical Studies

 
Products | Press Room | About Us | Contact Us | Site Map | Home